clonazepam has been researched along with Behavior Disorders in 30 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The diagnosis of schizophrenia is rapidly raised, motivating further prescription of loxapine 300 mg daily in combination with clonazepam 6 mg daily." | 3.78 | [Dysphagia or dysphagias during neuroleptic medication?]. ( Chaumartin, N; Lachaux, B; Monville, M, 2012) |
| "Behavioral side effects associated with clonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and temper tantrums." | 3.72 | Brief report: clonazepam behavioral side effects with an individual with mental retardation. ( Hanzel, TE; Harder, SR; Kalachnik, JE; Sevenich, R, 2003) |
| " Axis I and II psychiatric diagnosis was assessed and methadone dosage and history of abuse was recorded." | 2.71 | Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity. ( Adelson, M; Bleich, A; Gelkopf, M; Melamed, Y; Weizman, T, 2003) |
| "Sleep disorders and neurodegenerative diseases are commonly encountered in primary care." | 2.53 | Importance of Rapid Eye Movement Sleep Behavior Disorder to the Primary Care Physician. ( Howell, MJ; McCarter, SJ, 2016) |
| "The cornerstone of treatment for all parasomnias is adequate patient and bed partner education." | 2.46 | Parasomnias: an overview. ( Lee-Chiong, T; Matwiyoff, G, 2010) |
| "It is important to consider Wilson's disease in patients with psychiatric signs and symptoms who also have abnormal liver function test results or neurologic findings, or both." | 2.39 | Wilson's disease. Psychiatric manifestations may be the clinical presentation. ( Jackson, GH; Lippmann, S; Meyer, A, 1994) |
| "Clonazepam was discontinued." | 1.36 | Clonazepam and botulinum toxin for the treatment of alien limb phenomenon. ( Fernandez, HH; Haq, IU; Jacobson, CE; Malaty, IA; Okun, MS; Rodriguez, RR, 2010) |
| "QUESTIONSeveral of my patients with psychiatric disorders are either planning to conceive or are already pregnant." | 1.30 | Counseling psychiatric patients about drug exposures during pregnancy. ( Einarson, A; Koren, G, 1998) |
| "Clonazepam, which is a benzodiazepine structurally related to chlordiazepoxide hydrochloride, diazepam and nitrazepam, has been available for the treatment of seizure disorders in the USA since 1976 and in Japan since 1981." | 1.30 | Clonazepam as a therapeutic adjunct to improve the management of psychiatric disorders. ( Aoki, S; Morishita, S; Watanabe, S, 1998) |
| "In 100 consecutive adults who came to a sleep disorders center complaining of repeated nocturnal injury, polysomnographic study identified five disorders: night terrors/sleepwalking (N = 54), REM sleep behavior disorder (N = 36), dissociative disorders (N = 7), nocturnal seizures (N = 2), and sleep apnea (N = 1)." | 1.28 | A polysomnographic and clinical report on sleep-related injury in 100 adult patients. ( Bundlie, SR; Hurwitz, TD; Mahowald, MW; Milner, DM; Schenck, CH, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (23.33) | 18.7374 |
| 1990's | 10 (33.33) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, R | 1 |
| Bansal, P | 1 |
| Sharma, A | 1 |
| Chhabra, M | 1 |
| Bansal, N | 1 |
| Arora, M | 1 |
| Yang, Y | 1 |
| Wang, B | 1 |
| Zhong, Z | 1 |
| Chen, H | 1 |
| Ding, W | 1 |
| Hoi, MPM | 1 |
| Sohn, KC | 1 |
| Jeong, YH | 1 |
| Jo, DH | 1 |
| Heo, WG | 1 |
| Yeom, DH | 1 |
| Choi, SC | 1 |
| Ryu, HS | 1 |
| McCarter, SJ | 1 |
| Howell, MJ | 1 |
| Haq, IU | 1 |
| Malaty, IA | 1 |
| Okun, MS | 1 |
| Jacobson, CE | 1 |
| Fernandez, HH | 1 |
| Rodriguez, RR | 1 |
| Matwiyoff, G | 1 |
| Lee-Chiong, T | 1 |
| Seeman, MV | 1 |
| Chaumartin, N | 1 |
| Monville, M | 1 |
| Lachaux, B | 1 |
| Danhauer, SC | 1 |
| Miller, CS | 1 |
| Rhodus, NL | 1 |
| Carlson, CR | 1 |
| Weizman, T | 1 |
| Gelkopf, M | 1 |
| Melamed, Y | 1 |
| Adelson, M | 1 |
| Bleich, A | 1 |
| Kalachnik, JE | 1 |
| Hanzel, TE | 1 |
| Sevenich, R | 1 |
| Harder, SR | 1 |
| Kreisel, SH | 1 |
| Binder, J | 1 |
| Wöhrle, JC | 1 |
| Krauss, JK | 1 |
| Hofmann, S | 1 |
| Bauer, MF | 1 |
| Hennerici, MG | 1 |
| Bäzner, H | 1 |
| Raheja, RK | 1 |
| Bharwani, I | 1 |
| Penetrante, AE | 1 |
| Stoll, AL | 1 |
| Oepen, G | 1 |
| Hafner, RJ | 1 |
| Holme, G | 1 |
| Jackson, GH | 1 |
| Meyer, A | 1 |
| Lippmann, S | 1 |
| Freeman, S | 1 |
| Einarson, A | 1 |
| Koren, G | 1 |
| Morishita, S | 1 |
| Aoki, S | 1 |
| Watanabe, S | 1 |
| Rothschild, AJ | 1 |
| Shindul-Rothschild, JA | 1 |
| Viguera, A | 1 |
| Murray, M | 1 |
| Brewster, S | 1 |
| Bielmann, P | 1 |
| Levac, T | 1 |
| Gagnon, MA | 1 |
| Dumermuth, G | 1 |
| Gasser, T | 1 |
| Germann, P | 1 |
| Hecker, A | 1 |
| Herdan, M | 1 |
| Lange, B | 1 |
| Fenwick, PB | 1 |
| Schenck, CH | 1 |
| Milner, DM | 1 |
| Hurwitz, TD | 1 |
| Bundlie, SR | 1 |
| Mahowald, MW | 1 |
| Ghadirian, AM | 1 |
| Gauthier, S | 1 |
| Wong, T | 1 |
| Dubin, WR | 1 |
| Rosenbaum, JF | 1 |
5 reviews available for clonazepam and Behavior Disorders
| Article | Year |
|---|---|
Importance of Rapid Eye Movement Sleep Behavior Disorder to the Primary Care Physician.
Topics: Central Nervous System Depressants; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Me | 2016 |
Parasomnias: an overview.
Topics: Adolescent; Adult; Age of Onset; Aged; Clonazepam; Female; Humans; Male; Mental Disorders; Middle Ag | 2010 |
Wilson's disease. Psychiatric manifestations may be the clinical presentation.
Topics: Clonazepam; Copper; Cornea; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Liver Fu | 1994 |
Antiepileptic drugs and their psychotropic effects.
Topics: Affect; Anticonvulsants; Brain; Carbamazepine; Clonazepam; Epilepsy; Humans; Mental Disorders; Psych | 1992 |
Rapid tranquilization: antipsychotics or benzodiazepines?
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Humans; | 1988 |
4 trials available for clonazepam and Behavior Disorders
| Article | Year |
|---|---|
Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Anticonvulsants; Burning Mouth Syndrome; Carbam | 2002 |
Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity.
Topics: Adult; Anticonvulsants; Benzodiazepines; Chi-Square Distribution; Clonazepam; Comorbidity; Female; H | 2003 |
Clonazepam: its efficacy in association with phenytoin and phenobarbital in mental patients with generalized major motor seizures.
Topics: Benzodiazepinones; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Therapy, Combinat | 1978 |
Studies on EEG activities in the beta band.
Topics: Adolescent; Anticonvulsants; Beta Rhythm; Child; Clinical Trials as Topic; Clonazepam; Computers; El | 1977 |
21 other studies available for clonazepam and Behavior Disorders
| Article | Year |
|---|---|
Clonazepam tops the list of potentially inappropriate psychotropic (PIP) medications in older adults with psychiatric illness: A cross-sectional study based on Beers criteria 2019 vs STOPP criteria 2015.
Topics: Aged; Aged, 80 and over; Clonazepam; Cross-Sectional Studies; Humans; India; Mental Disorders; Poten | 2021 |
Clonazepam attenuates neurobehavioral abnormalities in offspring exposed to maternal immune activation by enhancing GABAergic neurotransmission.
Topics: Animals; Clonazepam; Female; GABA Modulators; GABA-A Receptor Agonists; GABAergic Neurons; Male; Men | 2021 |
A Case of Aerophagia Diagnosed by Multichannel Intraluminal Impedance Monitoring.
Topics: Adult; Aerophagy; Anticonvulsants; Clonazepam; Diagnosis, Differential; Electric Impedance; Humans; | 2015 |
Clonazepam and botulinum toxin for the treatment of alien limb phenomenon.
Topics: Adolescent; Alien Limb Phenomenon; Botulinum Toxins; Brain; Clonazepam; Female; Humans; Magnetic Res | 2010 |
Sleepwalking, a possible side effect of antipsychotic medication.
Topics: Anticonvulsants; Antipsychotic Agents; Clonazepam; Female; Humans; Mental Disorders; Middle Aged; Po | 2011 |
[Dysphagia or dysphagias during neuroleptic medication?].
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Clonazepam; Deglutition Disorders; Diagn | 2012 |
Brief report: clonazepam behavioral side effects with an individual with mental retardation.
Topics: Aggression; Anticonvulsants; Clonazepam; Humans; Intellectual Disability; Male; Mental Disorders; Mi | 2003 |
Dystonia in the Mohr-Tranebjaerg syndrome responds to GABAergic substances.
Topics: Adult; Clonazepam; Cognition Disorders; Dystonic Disorders; GABA Modulators; Genetic Diseases, X-Lin | 2004 |
Efficacy of risperidone for behavioral disorders in the elderly: a clinical observation.
Topics: Aged; Antipsychotic Agents; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1995 |
Comorbid social phobia: pharmacologic strategies.
Topics: Clinical Trials as Topic; Clonazepam; Comorbidity; Humans; Mental Disorders; Monoamine Oxidase Inhib | 1995 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; C | 1994 |
Zinc salts for the treatment of olfactory and gustatory symptoms in psychiatric patients: a case series.
Topics: Antipsychotic Agents; Clonazepam; Drug Therapy, Combination; Gluconates; Hallucinations; Hospitaliza | 1994 |
Electroconvulsive therapy in a psychiatric intensive care unit.
Topics: Adolescent; Adult; Australia; Carbamazepine; Clonazepam; Combined Modality Therapy; Electroconvulsiv | 1994 |
The realities of clonazepam discontinuation.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modul | 1997 |
Counseling psychiatric patients about drug exposures during pregnancy.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Clonazepam; Embryonic and Fetal Developmen | 1998 |
Clonazepam as a therapeutic adjunct to improve the management of psychiatric disorders.
Topics: Adult; Aged; Akathisia, Drug-Induced; Anticonvulsants; Bipolar Disorder; Clonazepam; Delusions; Depr | 1998 |
Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients.
Topics: Adolescent; Adult; Aged; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Behavioral Symptoms; | 2000 |
A polysomnographic and clinical report on sleep-related injury in 100 adult patients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clonazepam; Dissociative Disorders; Female; Humans | 1989 |
Convulsions in patients abruptly withdrawn from clonazepam while receiving neuroleptic medication.
Topics: Adult; Antipsychotic Agents; Clonazepam; Drug Therapy, Combination; Female; Humans; Male; Mental Dis | 1987 |
New uses for clonazepam in psychiatry. A symposium. Proceedings.
Topics: Clonazepam; Humans; Mental Disorders | 1987 |
New uses for clonazepam in psychiatry: introduction and overview.
Topics: Clonazepam; Humans; Mental Disorders | 1987 |